The Title of the Video Would Go Here

Press Release:

St. Vincent’s Hospital Implants Australia’s First Total Artificial Heart

Sydney Hospital to Serve as SynCardia’s Regional Certification Center for Asia-Pacific

Aug. 16, 2010: Angelo Tigano, the first patient to receive the SynCardia temporary Total Artificial Heart in the Southern Hemisphere, at a news conference at St. Vincent’s Hospital in Sydney, Australia.Aug. 16, 2010: Angelo Tigano, the first patient to receive the SynCardia temporary Total Artificial Heart in the Southern Hemisphere, at a news conference at St. Vincent’s Hospital in Sydney, Australia.

TUCSON, Ariz. – Aug. 19, 2010 – On Aug. 5, St. Vincent’s Hospital in Sydney performed Australia’s first implant of the SynCardia temporary Total Artificial Heart. The patient, a 50-year-old-male suffering from total heart failure, is the first recipient of the Total Artificial Heart in the Southern Hemisphere. The surgery was performed by heart surgeons Drs. Phillip Spratt and Paul Jansz. View extensive Media Coverage

“At any one time there can be around 30 people waiting for a heart transplant at our hospital,” said Dr. Spratt, Head of the St. Vincent’s Hospital Heart/Lung Transplant Unit. “We selected this patient to receive the Total Artificial Heart as a bridge-to-transplant because without it, he would have had less than two weeks to live.”

Dr. Phillip Spratt, A.M., Director of Cardiothoracic Surgery, St. Vincent's HospitalDr. Phillip Spratt, A.M., Director of Cardiothoracic Surgery, St. Vincent's Hospital

Angelo Tigano had suffered from idiopathic cardiomyopathy for more than a decade. Walking more than a few steps left him gasping for breath, until finally he was unable to eat or sleep. Mr. Tigano says he hopes the Total Artificial Heart will improve his quality of life and allow him to return to some of the normal activities he did before suffering heart failure.  

“The Total Artificial Heart has no equal,” said Dr. Spratt, who led the Total Artificial Heart implant surgery. “Unlike a left ventricular assist device (LVAD), which helps the failing left ventricle, the Total Artificial Heart replaces both the left and right heart ventricles which are responsible for pumping blood.”

The implant surgery was proctored by world renowned heart surgeon Dr. Jack Copeland, who recently joined the faculty at the University of California, San Diego, and has performed more than 100 implants of the Total Artificial Heart. St. Vincent’s Hospital is the 31st hospital in the world to become a SynCardia Certified Center. Currently, there are Certified Centers in the U.S., Canada, France, Germany, Italy, Sweden, Austria, Russia and now Australia.

Dr. Paul Jansz, Cardiothoracic Surgeon, St. Vincent's HospitalDr. Paul Jansz, Cardiothoracic Surgeon, St. Vincent's Hospital

St. Vincent’s is the largest transplant hospital in Australia and will serve as SynCardia’s Regional Certification Center for the Asia-Pacific. Device Technologies is the Australasian distributor of the SynCardia Total Artificial Heart and is a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand.

Cardiovascular disease is the leading cause of death in Australia. Despite the increase in this condition and consequent growing demand for transplants, the supply of donor hearts is falling in Australia. In 2009, a total of 60 heart transplants took place, compared with 82 in 2008. Australia has one of the lowest donation rates in the developed world with only 12 donors per million in 2008.

Source: http://www.donatelife.gov.au/Discover/Facts-and-Statistics.htm

###

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end stage heart failure affecting both sides of the heart (biventricular failure). More than 400 SynCardia Total Artificial Heart implants have been performed since January 2011. The SynCardia Heart has provided almost 130,000 patient days of support from nearly 1,300 implants. The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at 97 SynCardia Certified Centers worldwide with 39 others in the process of certification.

The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

For up-to-date information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

 

Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660

 

 

*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.

FREE News Sign-Up

3538727_sBe Among the First to
Receive SynCardia News

... right in your email box